Immune evasion of SARS-CoV-2 emerging variants: what have we learnt so far?
I Lazarevic, V Pravica, D Miljanovic, M Cupic - Viruses, 2021 - mdpi.com
Despite the slow evolutionary rate of SARS-CoV-2 relative to other RNA viruses, its massive
and rapid transmission during the COVID-19 pandemic has enabled it to acquire significant …
and rapid transmission during the COVID-19 pandemic has enabled it to acquire significant …
Mechanistic insights into the immune pathophysiology of COVID-19; an in-depth review
Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), which causes
coronavirus-19 (COVID-19), has caused significant morbidity and mortality globally. In …
coronavirus-19 (COVID-19), has caused significant morbidity and mortality globally. In …
Functional SARS-CoV-2 cross-reactive CD4+ T cells established in early childhood decline with age
M Humbert, A Olofsson, D Wullimann… - Proceedings of the …, 2023 - National Acad Sciences
Pre-existing SARS-CoV-2-reactive T cells have been identified in SARS-CoV-2-unexposed
individuals, potentially modulating COVID-19 and vaccination outcomes. Here, we provide …
individuals, potentially modulating COVID-19 and vaccination outcomes. Here, we provide …
Clinical characteristics of headache after vaccination against COVID-19 (coronavirus SARS-CoV-2) with the BNT162b2 mRNA vaccine: a multicentre observational …
CH Göbel, A Heinze, S Karstedt… - Brain …, 2021 - academic.oup.com
The novel coronavirus SARS-CoV-2 causes the infectious disease COVID-19. Newly
developed mRNA vaccines can prevent the spread of the virus. Headache is the most …
developed mRNA vaccines can prevent the spread of the virus. Headache is the most …
Evidence of previous SARS-CoV-2 infection in seronegative patients with long COVID
BA Krishna, EY Lim, L Mactavous, PA Lyons… - …, 2022 - thelancet.com
Background There is currently no consensus on the diagnosis, definition, symptoms, or
duration of COVID-19 illness. The diagnostic complexity of Long COVID is compounded in …
duration of COVID-19 illness. The diagnostic complexity of Long COVID is compounded in …
Headache attributed to vaccination against COVID-19 (coronavirus SARS-CoV-2) with the ChAdOx1 nCoV-19 (AZD1222) vaccine: a multicenter observational cohort …
CH Göbel, A Heinze, S Karstedt, M Morscheck… - Pain and therapy, 2021 - Springer
Introduction The most frequently reported neurological adverse event of ChAdOx1 nCoV-19
(AZD1222) vaccine is headache in 57.5%. Several cases of cerebral venous thrombosis …
(AZD1222) vaccine is headache in 57.5%. Several cases of cerebral venous thrombosis …
The immune response to SARS-CoV-2 vaccination: insights learned from adult patients with common variable immune deficiency
I Quinti, F Locatelli, R Carsetti - Frontiers in Immunology, 2022 - frontiersin.org
CVID patients have an increased susceptibility to vaccine-preventable infections. The
question on the potential benefits of immunization of CVID patients against SARS-CoV-2 …
question on the potential benefits of immunization of CVID patients against SARS-CoV-2 …
Common variable immunodeficiency disorders, T-cell responses to SARS-CoV-2 vaccines, and the risk of chronic COVID-19
R Ameratunga, H Longhurst, R Steele, K Lehnert… - The Journal of Allergy …, 2021 - Elsevier
COVID-19 has had a calamitous effect on the global community. Despite intense study, the
immunologic response to the infection is only partially understood. In addition to older age …
immunologic response to the infection is only partially understood. In addition to older age …
SARS-CoV-2 T cell response in severe and fatal COVID-19 in primary antibody deficiency patients without specific humoral immunity
S Steiner, T Schwarz, VM Corman, L Gebert… - Frontiers in …, 2022 - frontiersin.org
Morbidity and mortality of COVID-19 is increased in patients with inborn errors of immunity
(IEI). Age and comorbidities and also impaired type I interferon immunity were identified as …
(IEI). Age and comorbidities and also impaired type I interferon immunity were identified as …
Association of cellular immunity with severity of COVID-19 from the perspective of antigen-specific memory T cell responses and cross-reactivity
S Fujii, S Yamasaki, T Iyoda, K Shimizu - Inflammation and Regeneration, 2022 - Springer
Coronaviruses regularly cause outbreaks of zoonotic diseases characterized by severe
pneumonia. The new coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS …
pneumonia. The new coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS …